Sign in to view content

Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker For the Treatment of Diabetic Macular Edema (DME)

Victor Hugo Gonzalez, MD

Video
Published 2024

Related

Advances in Diabetic Vitrectomy
Judy E. Kim, MD, FASRS
Updates from the Field
2016
Foveal Capillary Perfusion Density Decreases in Diabetics with DME Treated on a Fixed Regimen of Intravitreal Aflibercept Injections Over 24 Months
Brittney Statler, MD
Updates from the Field
2020
Anti-VEGF Injections and Risk of Traction Retinal Detachments in Eyes With Proliferative Diabetic Retinopathy: Pooled Analysis of 5 DRCR.net Trials
Hani Salehi-Had, MD, FASRS
Updates from the Field

Category: Diabetic Retinopathy

See more